+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computer-aided Drug Discovery Market by Molecule Type, Deployment Model, Pricing Model, End User, Type, Technology, Application - Global Forecast to 2030- Product Image
Computer-aided Drug Discovery Market by Molecule Type, Deployment Model, Pricing Model, End User, Type, Technology, Application - Global Forecast to 2030- Product Image
Sale

Computer-aided Drug Discovery Market by Molecule Type, Deployment Model, Pricing Model, End User, Type, Technology, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967979
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The computer-aided drug discovery market is transforming pharmaceutical R&D practices, empowering organizations to accelerate development and improve target precision by integrating computational techniques at every stage of the discovery pipeline.

Market Snapshot: Computer-Aided Drug Discovery Growth and Outlook

The computer-aided drug discovery market grew from USD 4.08 billion in 2024 to USD 4.49 billion in 2025. It is expected to continue growing at a CAGR of 9.80%, reaching USD 7.16 billion by 2030.

Scope & Segmentation

  • Molecule Type: Biologics, Small Molecules
  • Deployment Model: Cloud-Based, On-Premises
  • Pricing Model: Pay Per Use, Perpetual License, Subscription
  • End User: Academic And Government Institutes, Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies
  • Type: Consulting, Implementation, Research Outsourcing, Support And Maintenance, Data Analytics, De Novo Design, Molecular Modeling (Ligand Based Design, Structure Based Design), QSAR Modeling, Virtual Screening
  • Technology: ADMET Prediction, Bioinformatics (Functional Genomics, Sequence Analysis), Chemoinformatics (Library Design, QSAR Modeling, Scaffold Hopping), De Novo Design, Molecular Modeling
  • Application: Clinical Trials Support, Lead Discovery, Lead Optimization, Preclinical Development, Target Identification
  • Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: Schrödinger, Inc.; Dassault Systèmes SE; Certara, L.P.; Exscientia Limited; Atomwise, Inc.; Cresset, Ltd.; OpenEye Scientific Software, Inc.; Nimbus Therapeutics, LLC; Insilico Medicine, Inc.; BenevolentAI Limited

Key Takeaways: Strategic Insights for Decision Makers

  • Computational and in silico strategies are becoming integral parts of drug discovery workflows, reducing timelines and optimizing molecule selection for both biologics and small molecules.
  • Artificial intelligence, machine learning, and high-performance computing are advancing molecular modeling, virtual screening, and predictive analytics, enhancing the accuracy of target identification.
  • Market demand spans organizations from academic research institutes to global pharmaceutical companies, each seeking scalable, adaptable computational tools and flexible deployment models.
  • Cloud-based solutions are enabling rapid onboarding and cost-effective access, while on-premises installations remain valued for security and control in established enterprises.
  • The convergence of bioinformatics, chemoinformatics, and predictive modeling is expanding applications, from preclinical development to clinical trials support, fostering cross-disciplinary innovation.

Tariff Impact and Market Adaptation

Recent tariffs introduced by the United States in 2025 have added complexity to R&D economics, particularly affecting costs of imported computational hardware and specialized laboratory reagents. Organizations are adjusting by shifting toward cloud-based deployment, reevaluating supplier relationships, and adopting flexible sourcing and inventory management strategies. Consortia and regional collaborations are emerging as favored approaches to manage procurement and sustain continuity amidst evolving trade regulations.

Methodology & Data Sources

This report synthesizes findings from secondary sources, peer-reviewed publications, and patent databases, supplemented by interviews with R&D, software development, and regulatory experts across the value chain. Quantitative analysis leveraged vendor data, usage metrics, and surveys, with triangulation to validate trends and insights.

Why This Report Matters

  • Helps decision makers benchmark strategic investments by providing actionable intelligence on deployment models, adoption drivers, and emerging technologies in computer-aided drug discovery.
  • Offers granular segmentation and regional analysis, enabling organizations to adapt strategies to local market conditions and harness collaborative innovation networks.

Conclusion

Computer-aided drug discovery is reshaping pharmaceutical research through advanced computational tools, adaptive strategies, and cross-disciplinary innovation. This report is designed to guide senior leaders in capitalizing on these trends for superior R&D outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Computer-aided Drug Discovery Market, by Molecule Type
8.1. Introduction
8.2. Biologics
8.3. Small Molecules
9. Computer-aided Drug Discovery Market, by Deployment Model
9.1. Introduction
9.2. Cloud-Based
9.3. on-Premises
10. Computer-aided Drug Discovery Market, by Pricing Model
10.1. Introduction
10.2. Pay Per Use
10.3. Perpetual License
10.4. Subscription
11. Computer-aided Drug Discovery Market, by End User
11.1. Introduction
11.2. Academic and Government Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Computer-aided Drug Discovery Market, by Type
12.1. Introduction
12.2. Services
12.2.1. Consulting
12.2.2. Implementation
12.2.3. Research Outsourcing
12.2.4. Support and Maintenance
12.3. Software
12.3.1. Data Analytics
12.3.2. De Novo Design
12.3.3. Molecular Modeling
12.3.3.1. Ligand Based Design
12.3.3.2. Structure Based Design
12.3.4. QSAR Modeling
12.3.5. Virtual Screening
13. Computer-aided Drug Discovery Market, by Technology
13.1. Introduction
13.2. ADMET Prediction
13.3. Bioinformatics
13.3.1. Functional Genomics
13.3.2. Sequence Analysis
13.4. Chemoinformatics
13.4.1. Library Design
13.4.2. QSAR Modeling
13.4.3. Scaffold Hopping
13.5. De Novo Design
13.6. Molecular Modeling
14. Computer-aided Drug Discovery Market, by Application
14.1. Introduction
14.2. Clinical Trials Support
14.3. Lead Discovery
14.4. Lead Optimization
14.5. Preclinical Development
14.6. Target Identification
15. Americas Computer-aided Drug Discovery Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Computer-aided Drug Discovery Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Computer-aided Drug Discovery Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Schrödinger, Inc.
18.3.2. Dassault Systèmes SE
18.3.3. Certara, L.P.
18.3.4. Exscientia Limited
18.3.5. Atomwise, Inc.
18.3.6. Cresset, Ltd.
18.3.7. OpenEye Scientific Software, Inc.
18.3.8. Nimbus Therapeutics, LLC
18.3.9. Insilico Medicine, Inc.
18.3.10. BenevolentAI Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET MULTI-CURRENCY
FIGURE 2. COMPUTER-AIDED DRUG DISCOVERY MARKET MULTI-LANGUAGE
FIGURE 3. COMPUTER-AIDED DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. COMPUTER-AIDED DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. COMPUTER-AIDED DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 85. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 86. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 90. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 91. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 93. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 94. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 98. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 103. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 157. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 158. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 159. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 164. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 170. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 171. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 174. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 176. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 194. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 195. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 199. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 200. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 202. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 203. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 206. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 207. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 212. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 214. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 215. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 254. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 255. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 259. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 260. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 262. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 263. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 277. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 278. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 279. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 282. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 283. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 284. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 286. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 287. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 289. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 290. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 291. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 294. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 295. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 296. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 298. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 299. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD MILLION)
TABLE 310. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Computer-aided Drug Discovery market report include:
  • Schrödinger, Inc.
  • Dassault Systèmes SE
  • Certara, L.P.
  • Exscientia Limited
  • Atomwise, Inc.
  • Cresset, Ltd.
  • OpenEye Scientific Software, Inc.
  • Nimbus Therapeutics, LLC
  • Insilico Medicine, Inc.
  • BenevolentAI Limited

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.16 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Computer-Aided Drug Discovery Market Report 2025 - Product Image

Computer-Aided Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Computer-Aided Drug Discovery - Global Strategic Business Report - Product Image

Computer-Aided Drug Discovery - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Computer-Aided Drug Discovery Market - Forecasts from 2025 to 2030 - Product Image

Computer-Aided Drug Discovery Market - Forecasts from 2025 to 2030

  • Report
  • 140 Pages
  • Global
From
2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report - Product Image

2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report

  • Report
  • 70 Pages
  • Global
From
2025 Global Forecast for Computer-Aided Drug Discovery Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Computer-Aided Drug Discovery Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Computer Aided Drug Discovery Market

Computer Aided Drug Discovery (CADD) is a technology-driven approach to drug discovery that uses computer-based methods to identify and develop new drugs. CADD combines the power of computational chemistry, bioinformatics, and machine learning to identify and optimize potential drug candidates. CADD can be used to identify novel drug targets, design and optimize drug molecules, and predict drug-target interactions. CADD can also be used to predict drug metabolism and toxicity, and to identify potential drug-drug interactions. CADD has become an important tool in the drug discovery process, allowing researchers to rapidly identify and develop new drugs. CADD can reduce the time and cost associated with drug discovery, and can help to identify novel drug targets and optimize drug molecules. Some companies in the CADD market include Schrödinger, ChemAxon, Accelrys, and OpenEye Scientific Software. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.